GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helixmith Co Ltd (XKRX:084990) » Definitions » Ending Cash Position

Helixmith Co (XKRX:084990) Ending Cash Position : ₩70,853 Mil (As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is Helixmith Co Ending Cash Position?

Helixmith Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ₩70,853 Mil.

Helixmith Co's quarterly Ending Cash Position declined from Sep. 2024 (₩37,204 Mil) to Dec. 2024 (₩36,841 Mil) but then increased from Dec. 2024 (₩36,841 Mil) to Mar. 2025 (₩70,853 Mil).

Helixmith Co's annual Ending Cash Position declined from Dec. 2022 (₩46,396 Mil) to Dec. 2023 (₩44,653 Mil) and declined from Dec. 2023 (₩44,653 Mil) to Dec. 2024 (₩36,841 Mil).

Helixmith Co Ending Cash Position Historical Data

The historical data trend for Helixmith Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helixmith Co Ending Cash Position Chart

Helixmith Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 192,300.72 42,381.91 46,395.54 44,653.32 36,840.72

Helixmith Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,658.69 9,401.01 37,204.22 36,840.72 70,852.85

Helixmith Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Helixmith Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=44653.32+-7812.602
=36,841

Helixmith Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=36840.718+34012.127
=70,853

Helixmith Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Helixmith Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Helixmith Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helixmith Co Ltd (XKRX:084990) » Definitions » Ending Cash Position
Comparable Companies
XKRX:278650 XKRX:311690 XKRX:048530 XKRX:235980 XKRX:338840 XKRX:214260 XKRX:251120 XKRX:456070 XKRX:217730 XKRX:299660 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
1 Gwanak-ro, Gwanak-gu, 5th Floor, Building Number 203, Seoul National University, Seoul, KOR, 08826
Website
https://www.helixmith.com
Helixmith Co Ltd, formerly ViroMed Co Ltd is active in the healthcare sector in Korea. The company specializes in developing pharmaceutical products for the treatment of diseases related to peripheral artery, coronary artery, cardiovascular system and neuropathy, cancer and allergy. Its suite of products includes protein/deoxyribonucleic acid (DNA)-based biopharmaceuticals, botanical drugs and natural pharmaceuticals.

Helixmith Co Headlines

No Headlines